AR029442A1 - Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios - Google Patents

Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios

Info

Publication number
AR029442A1
AR029442A1 ARP010100515A ARP010100515A AR029442A1 AR 029442 A1 AR029442 A1 AR 029442A1 AR P010100515 A ARP010100515 A AR P010100515A AR P010100515 A ARP010100515 A AR P010100515A AR 029442 A1 AR029442 A1 AR 029442A1
Authority
AR
Argentina
Prior art keywords
formula
compound
production
reacting
alkyl
Prior art date
Application number
ARP010100515A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9885081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029442(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR029442A1 publication Critical patent/AR029442A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un proceso para la produccion de un compuesto de formula (3), cuando R1 es alquilo (C1-4) mediante carbamoilacion de un compuesto de formula (2) con un cianato de metal; un proceso para la produccion de un compuesto de formula (5) en donde R2 es alquilo C1-4 o fenilo que comprende el cierre de anillo de un compuesto de formula (6), un proceso para la produccion de un compuesto de formula (5), que comprende el cierre de anillo de un compuesto de formula (7) en donde R3 y R4 independientemente son alquilo (C1-4); un proceso para la produccion de un compuesto de formula (1) que comprende reaccionar un compuesto de formula (5) con un compuesto de formula R1OH o (R1O)3CH; un proceso para la produccion de un compuesto de formula (6) que comprende reaccionar el compuesto de formula (8) bajo severas condiciones básicas con un compuesto de formula X-COOR2, en donde X es cloro o metoxilo; un procedimiento para la produccion de un compuesto de formula VII que comprende reaccionar un compuesto de formula (9) con un compuesto de formula CICOOR2, en donde R2 no es tert butilo, cuando R3 y R4 son ambos isopropilo y un proceso para la produccion de un compuesto de la formula (9) que comprende reaccionar el compuesto de formula (10) con un compuesto de formula R3-NH-R4. Los compuestos de formula (1), (5), (6), (7) y (9). Estos compuestos son utiles como intermediarios para la preparacion de oxcarbazepina.
ARP010100515A 2000-02-07 2001-02-05 Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios AR029442A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0002740.9A GB0002740D0 (en) 2000-02-07 2000-02-07 Organic compounds

Publications (1)

Publication Number Publication Date
AR029442A1 true AR029442A1 (es) 2003-06-25

Family

ID=9885081

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010100515A AR029442A1 (es) 2000-02-07 2001-02-05 Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios
ARP100104442A AR079237A2 (es) 2000-02-07 2010-12-01 Proceso para la preparacion de derivados de dibenzo(b,f) azepina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP100104442A AR079237A2 (es) 2000-02-07 2010-12-01 Proceso para la preparacion de derivados de dibenzo(b,f) azepina

Country Status (34)

Country Link
US (1) US7112673B2 (es)
EP (2) EP2067772B1 (es)
JP (1) JP4859322B2 (es)
KR (5) KR101216285B1 (es)
CN (2) CN100455572C (es)
AR (2) AR029442A1 (es)
AT (2) ATE505459T1 (es)
AU (1) AU767724B2 (es)
BR (1) BR0107922A (es)
CA (3) CA2724295C (es)
CO (1) CO5271705A1 (es)
CY (1) CY1111567T1 (es)
CZ (1) CZ301572B6 (es)
DE (2) DE60138271D1 (es)
DK (1) DK2067772T3 (es)
ES (2) ES2324900T3 (es)
GB (1) GB0002740D0 (es)
HK (1) HK1052501A1 (es)
HU (1) HU229420B1 (es)
IL (3) IL150613A0 (es)
MX (1) MXPA02007629A (es)
MY (1) MY136474A (es)
NO (1) NO324949B1 (es)
NZ (1) NZ520329A (es)
PE (1) PE20011078A1 (es)
PL (2) PL217225B1 (es)
PT (2) PT2067772E (es)
RU (1) RU2303591C2 (es)
SI (1) SI2067772T1 (es)
SK (1) SK287217B6 (es)
TR (1) TR200201655T2 (es)
TW (1) TWI284638B (es)
WO (1) WO2001056992A2 (es)
ZA (1) ZA200206219B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
EP1302464A1 (en) * 2001-10-09 2003-04-16 Max India Limited Process for preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
ITMI20040452A1 (it) 2004-03-09 2004-06-09 Clariant Lsm Italia Spa Processo per la preparazione di oxcarbazepina
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
EP2359830B1 (en) * 2006-04-26 2012-09-19 Supernus Pharmaceuticals, Inc. Controlled released preparations of oxcarbazepine having sigmoidal release profile
US20090082335A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched oxcarbazepine
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
US20150232426A1 (en) 2012-09-26 2015-08-20 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP3043790B1 (en) 2013-09-11 2021-05-26 The Administrators of the Tulane Educational Fund Novel anthranilic amides and the use thereof
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847374A (en) * 1987-01-27 1989-07-11 Ciba-Geigy Corporation Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
IT1283594B1 (it) 1996-04-12 1998-04-22 Trifarma Srl Derivati della 5h-dibenz- (b,f)-azepin-5-carbossiammide, loro preparazione e uso come sostanze ad azione medicinale
DE69836378T2 (de) * 1997-07-01 2007-10-11 Warner-Lambert Co. Llc Benzoesäure- und Benzamid-Derivate von Anthranilsäure und ihre Anwendung als MEK-Inhibitoren
US6048856A (en) 1997-12-17 2000-04-11 Novo Nordisk A/S Heterocyclic compounds

Also Published As

Publication number Publication date
PE20011078A1 (es) 2001-11-16
ES2363490T3 (es) 2011-08-05
GB0002740D0 (en) 2000-03-29
HK1052501A1 (en) 2003-09-19
CA2639210C (en) 2011-05-03
IL150613A (en) 2010-05-17
CA2724295A1 (en) 2001-08-09
CZ301572B6 (cs) 2010-04-21
RU2303591C2 (ru) 2007-07-27
ATE505459T1 (de) 2011-04-15
PL392476A1 (pl) 2010-11-22
AU767724B2 (en) 2003-11-20
CA2395601C (en) 2010-01-05
EP2067772A3 (en) 2009-08-19
AR079237A2 (es) 2012-01-04
HUP0300243A3 (en) 2005-07-28
PT1265868E (pt) 2009-07-15
NO20023575L (no) 2002-07-26
US7112673B2 (en) 2006-09-26
CY1111567T1 (el) 2015-10-07
RU2002123334A (ru) 2004-01-10
IL150613A0 (en) 2003-02-12
JP4859322B2 (ja) 2012-01-25
ATE427938T1 (de) 2009-04-15
CN100455572C (zh) 2009-01-28
KR100931753B1 (ko) 2009-12-14
EP2067772A2 (en) 2009-06-10
KR100966209B1 (ko) 2010-06-25
SK287217B6 (sk) 2010-03-08
NZ520329A (en) 2003-11-28
CN1244563C (zh) 2006-03-08
TWI284638B (en) 2007-08-01
CA2395601A1 (en) 2001-08-09
PT2067772E (pt) 2011-07-13
PL214039B1 (pl) 2013-06-28
WO2001056992A2 (en) 2001-08-09
EP1265868A2 (en) 2002-12-18
KR20080103608A (ko) 2008-11-27
HUP0300243A2 (hu) 2003-06-28
AU4237301A (en) 2001-08-14
KR20090102882A (ko) 2009-09-30
KR20020071033A (ko) 2002-09-11
KR20080003016A (ko) 2008-01-04
DK2067772T3 (da) 2011-07-18
ES2324900T3 (es) 2009-08-19
JP2003521536A (ja) 2003-07-15
SI2067772T1 (sl) 2011-08-31
SK11262002A3 (sk) 2003-02-04
WO2001056992A3 (en) 2002-01-24
CA2724295C (en) 2011-07-26
TR200201655T2 (tr) 2002-11-21
CA2639210A1 (en) 2001-08-09
KR20100018069A (ko) 2010-02-16
MXPA02007629A (es) 2002-12-13
ZA200206219B (en) 2003-04-04
KR101216285B1 (ko) 2012-12-28
CN1394204A (zh) 2003-01-29
DE60144456D1 (de) 2011-05-26
MY136474A (en) 2008-10-31
EP1265868B1 (en) 2009-04-08
NO324949B1 (no) 2008-01-14
BR0107922A (pt) 2002-10-22
HU229420B1 (en) 2013-12-30
CZ20022676A3 (cs) 2002-11-13
CN1721409A (zh) 2006-01-18
US20030032800A1 (en) 2003-02-13
CO5271705A1 (es) 2003-04-30
PL217225B1 (pl) 2014-06-30
DE60138271D1 (de) 2009-05-20
EP2067772B1 (en) 2011-04-13
IL188183A (en) 2011-02-28
PL356404A1 (en) 2004-06-28
NO20023575D0 (no) 2002-07-26

Similar Documents

Publication Publication Date Title
AR029442A1 (es) Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios
DK1369409T3 (da) Fremgangsmåde til fremstilling af forbindelser, der er anvendelige som mellemprodukter
IL158798A0 (en) Synthesis of cannabinoids
GB2360281A (en) Method for the preparation of citalopram
PT1442006E (pt) Preparacao de anfetaminas a partir de fenilpropanolaminas
AU2001267452A1 (en) Process for the synthesis of amine ethers from secondary amino oxides
IL110432A (en) Process for the preparation of difluorobutenyl mercapto-heterocycles
ES8609285A1 (es) Procedimiento para preparar derivados de tetrazol con acti- vidad insecticida
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
ES2060250T3 (es) Procedimiento para producir beta-caroteno y compuestos intermedios utiles para el procedimiento.
HK1037617A1 (en) Process for the preparation of imidazodiazepine intermediates
TW334337B (en) Preparation and composition for a compound of controlling and preventing phytopathogenic fungi
DE69422495D1 (de) Chinolondisulfide als zwischenverbindungen
IL137118A0 (en) Process for the preparation of s-alkylcysteines
AU549269B2 (en) 3-acylamino-4-sulfonyl-2-azetidinones
WO2003019383A1 (en) Crystalline aluminophosphate production process and crystalline aluminophosphate
TW349935B (en) Oxime ether compounds, their intermediates and their use as pesticides
KR970006272A (ko) 자외선 흡수물질의 신규제조방법
AR005853A1 (es) Metodo para la preparacion de citalopram, e intermediarios para la preparacion de citalopram
TH36107A (th) สารประกอบชนิดใหม่
KR970061890A (ko) 치환된 5-하이드록시-4h-[1,3]-벤조디옥신-4-온 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee